RP
ABBV icon

Richard Pzena’s AbbVie ABBV Stock Holding History

Richard Pzena’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,670
Closed -$297K – 147
2024
Q4 		$297K Buy
+1,670
New +$307K ﹤0.01% 142
2021
Q2 		– Sell
-6,344
Closed -$687K – 166
2021
Q1 		$687K Buy
6,344
+111
+2% +$11.9K ﹤0.01% 145
2020
Q4 		$668K Buy
6,233
+138
+2% +$13.3K ﹤0.01% 145
2020
Q3 		$534K Sell
6,095
-1,130
-16% -$106K ﹤0.01% 152
2020
Q2 		$709K Sell
7,225
-824
-10% -$72.5K ﹤0.01% 148
2020
Q1 		$613K Buy
8,049
+4,870
+153% +$415K ﹤0.01% 155
2019
Q4 		$281K Hold
3,179
– – ﹤0.01% 168
2019
Q3 		$241K Buy
+3,179
New +$218K ﹤0.01% 170
2017
Q3 		– Sell
-5,137
Closed -$372K – 152
2017
Q2 		$372K Buy
5,137
+967
+23% +$65K ﹤0.01% 140
2017
Q1 		$272K Buy
4,170
+694
+20% +$43.6K ﹤0.01% 147
2016
Q4 		$218K Buy
+3,476
New +$212K ﹤0.01% 154

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Richard Pzena's ABBV Position: Q1 2025 in Review

Richard Pzena sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,670 shares — an estimated $297K sold.

Richard Pzena first reported a position in ABBV in Q4 2016 and held it in 11 quarters. The position peaked at $709K in Q2 2020. 3,824 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Richard Pzena reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Richard Pzena sold 1,670 AbbVie shares in Q1 2025, an estimated $297K.
  • Richard Pzena first reported a position in AbbVie in Q4 2016 and held it in 11 quarters.
  • Richard Pzena's AbbVie position peaked at $709K in Q2 2020.
  • 3,824 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Pzena Investment Management's 13F filing for Q1 2025, filed 2 May 2025.